Key result
Targeting mitochondrial dysfunction offers promising therapeutic pathways for heart failure.
Targeting mitochondrial dysfunction, specifically through biogenesis, oxidative stress reduction, and iron handling, represents a promising therapeutic avenue for heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bayeva et al. (2012) conducted a review in Heart failure. Mitochondria-targeted therapies was evaluated. Targeting mitochondrial dysfunction through biogenesis, oxidative stress, and iron handling represents a promising therapeutic approach for heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: